Kiora Pharmaceuticals Analyst Ratings
Kiora Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/24/2023 | 220% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 08/14/2023 | 220% | HC Wainwright & Co. | $7 → $2 | Maintains | Buy |
| 08/09/2023 | 220% | Maxim Group | $12 → $2 | Maintains | Buy |
| 05/12/2023 | 1020% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 03/24/2023 | 860% | HC Wainwright & Co. | $10 → $6 | Reiterates | → Buy |
| 02/09/2023 | 1820% | Maxim Group | → $12 | Upgrades | Hold → Buy |
| 02/08/2023 | 1500% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 02/08/2023 | 18940% | Ladenburg Thalmann | → $119 | Reiterates | → Buy |
| 08/25/2022 | 940% | Ladenburg Thalmann | → $6.5 | Initiates Coverage On | → Buy |
| 08/15/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 07/11/2022 | 300% | HC Wainwright & Co. | $3 → $2.5 | Maintains | Buy |
| 04/19/2022 | 380% | HC Wainwright & Co. | $5 → $3 | Maintains | Buy |
| 01/19/2022 | 300% | Maxim Group | → $2.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月24日 | 220% | HC Wainwright公司 | →$2 | 重申 | 購買→購買 |
| 2023年08月14日 | 220% | HC Wainwright公司 | $7→$2 | 維護 | 買 |
| 08/09/2023 | 220% | Maxim集團 | $12→$2 | 維護 | 買 |
| 2023年05月12日 | 1020% | HC Wainwright公司 | $6→$7 | 維護 | 買 |
| 03/24/2023 | 860% | HC Wainwright公司 | $10→$6 | 重申 | →購買 |
| 02/09/2023 | 1820% | Maxim集團 | →$12 | 升級 | 持有→購買 |
| 02/08/2023 | 1500% | HC Wainwright公司 | →$10 | 重申 | →購買 |
| 02/08/2023 | 18940% | 拉登堡·塔爾曼 | →$119 | 重申 | →購買 |
| 2022年08月25日 | 940% | 拉登堡·塔爾曼 | →$6.5 | 開始承保 | →購買 |
| 2022年08月15日 | - | Maxim集團 | 評級下調 | 購買→Hold | |
| 07/11/2022 | 百分之三百 | HC Wainwright公司 | $3→$2.5 | 維護 | 買 |
| 04/19/2022 | 380% | HC Wainwright公司 | $5→$3 | 維護 | 買 |
| 2022年1月19日 | 百分之三百 | Maxim集團 | →$2.5 | 開始承保 | →購買 |
What is the target price for Kiora Pharmaceuticals (KPRX)?
Kiora製藥公司(KPRX)的目標價是多少？
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on August 24, 2023. The analyst firm set a price target for $2.00 expecting KPRX to rise to within 12 months (a possible 220.00% upside). 9 analyst firms have reported ratings in the last year.
2023年8月24日，HC Wainwright&Co.報道了Kiora製藥公司(納斯達克代碼：KPRX)的最新目標價。這家分析公司將目標價定為2美元，預計KPRX將在12個月內上漲(可能上漲220.00%)。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Kiora Pharmaceuticals (KPRX)?
分析師對Kiora製藥(KPRX)的最新評級是多少？
The latest analyst rating for Kiora Pharmaceuticals (NASDAQ: KPRX) was provided by HC Wainwright & Co., and Kiora Pharmaceuticals reiterated their buy rating.
分析師對Kiora製藥(納斯達克代碼：KPRX)的最新評級由HC Wainwright&Co.提供，Kiora製藥重申其買入評級。
When is the next analyst rating going to be posted or updated for Kiora Pharmaceuticals (KPRX)?
Kiora PharmPharmticals(KPRX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kiora Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kiora Pharmaceuticals was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Kiora製藥的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Kiora製藥的上一次評級是在2023年8月24日提交的，所以你應該預計下一次評級將在2024年8月24日左右的某個時候公佈。
Is the Analyst Rating Kiora Pharmaceuticals (KPRX) correct?
分析師對Kiora製藥(KPRX)的評級正確嗎？
While ratings are subjective and will change, the latest Kiora Pharmaceuticals (KPRX) rating was a reiterated with a price target of $0.00 to $2.00. The current price Kiora Pharmaceuticals (KPRX) is trading at is $0.63, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Kiora製藥(KPRX)評級被重申，目標價在0.00美元至2.00美元之間。Kiora製藥(KPRX)目前的交易價格為0.63美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。